The pharmaceutical goods market in Finland has shown a consistent decline over the past decade. From a market size value of $249.16 million in 2013, it has decreased to $126.14 million in 2023, marking a significant downtrend. The year-on-year variation has oscillated, with the most noteworthy drops occurring in 2018 (-14.87%) and 2023 (-7.99%). The Compound Annual Growth Rate (CAGR) over the last five years is approximately -5.89%, indicating an average yearly decline in market size.
Looking into the forecasted data, the market is expected to continue shrinking from $115.29 million in 2024 to $72.98 million in 2028. The forecasted 5-year CAGR stands at -8.74%, with a projected 36.7% reduction over this five-year period.
Future trends to watch for:
- Increasing costs and restrictive healthcare policies impacting market size.
- Potential shifts towards generic drugs and alternative treatments.
- Technological advancements and innovations in the pharmaceutical industry.
